[1. Anderson KE, Bloomer JR, Bonkovsky HL, Kushner JP, Pierach CA, Pimstone NR, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005;142(6):439-50. DOI: 10.7326/0003-4819-142-6-200503150-0001010.7326/0003-4819-142-6-200503150-0001015767622]Search in Google Scholar
[2. Balwani M, Desnick RJ. The porphyrias: advances in diagnoses and treatment. Blood. 2012;120(23):4496-504 DOI: 10.1182/blood-2012-05-42318610.1182/blood-2012-05-423186351222922791288]Search in Google Scholar
[3. Palmieri C, Vigushin DM, Peters TJ. Managing malignant disease in patients with porphyria. QJM. 2004;97(3):115-26. DOI: 10.1093/qjmed/hch02710.1093/qjmed/hch02714976268]Search in Google Scholar
[4. Abel G, Palmer-Toy D. Heme synthesis and catabolism. In: McClatchey KD, ed. Clinical Laboratory Medicine. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins. 2002;407-17.]Search in Google Scholar
[5. Bonkovsky HL. Neurovisceral Porphyrias: What a hematologist needs to know. Hematology Am Soc Hematol Educ Program. 2005:24-30. DOI: 10.1182/asheducation-2005.1.2410.1182/asheducation-2005.1.2416304355]Search in Google Scholar
[6. Abou-Zeid Elias, Donofrio PD. Porphyric neuropathies. In: Donofrio PD, ed. Textbook of Peripheral Neuropathy. New York, Demos Medical Publishing. 2012;289-307.]Search in Google Scholar
[7. Kauppinen R, Mustajki P. Prognosis of acute intermittent porphyria: occurrence of acute attacks, precipitating factors and associated disease. Medicine (Baltimore). 1992;71(1):1-13.10.1097/00005792-199201000-00001]Search in Google Scholar
[8. Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN.. Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clin Chem. 2009;55(7):1406-14. DOI: 10.1373/ clinchem.2008.12256410.1373/clinchem.2008.12256419460837]Search in Google Scholar
[9. Tortorelli S, Kloke K, Raymond K. Chapter 15: Disorders of porphyrin metabolism. In Biochemical and Molecular Basis of Pediatric Disease. Fourth edition. Edited by DJ Dietzen, MJ Bennett, ECC Wong. AACC Press, 2010;307-24.]Search in Google Scholar
[10. Nuttall KL, Klee GG. Analyses of hemoglobin metabolism - porphyrins, iron, and bilirubin. In Tietz Textbook of Clinical Chemistry. Fifth edition. Edited by CA Burtis, ER Ashwood. Philadelphia, WB Saunders Company, 2001;584-607.]Search in Google Scholar
[11. American porphyria foundation. Porphyrins & Porphyria diagnosis. Available from: http://www.porphyriafoundation.com]Search in Google Scholar
[12. Ridley A. The neuropathy of acute intermittent porphyria. Q J Med. 1969;38(151):307-33.]Search in Google Scholar
[13. Ventura P, Cappellini MD, Rocchi E. The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine. Intern Emerg Med. 2009 Aug;4(4):297-308. DOI: 10.1007/s11739-009-0261-410.1007/s11739-009-0261-419479318]Search in Google Scholar
[14. Mustajoki P, Nordmann Y. Early administration of Haeme arginate for acute porphyric attacks. Arch Intern Med. 1993;153(17):2004-8. DOI: 10.1001/ archinte.1993.0041017007800810.1001/archinte.153.17.2004]Search in Google Scholar
[15. Bottomley SS. Porphyria. in: IIth Edition Wintrobe’s clinical hematology. Edited by Greer JP, Foerster J, Lukens JN. Philadelphia Lippincott Williams Wilkins 2004;1057-87.]Search in Google Scholar